title: The third intracellular loop and carboxyl tail of neurokinin 1 and 3 receptors determine interactions with beta-arrestins.
abstract: Tachykinins interact with three neurokinin receptors (NKRs) that are often coexpressed by the same cell. Cellular responses to tachykinins depend on the NKR subtype that is activated. We compared the colocalization of NK1R and NK3R with beta-arrestins 1 and 2, which play major roles in receptor desensitization, endocytosis, and signaling. In cells expressing NK1R, the selective agonist Sar-Met-substance P induced rapid translocation of beta-arrestins 1 and 2 from the cytosol to the plasma membrane and then endosomes, indicative of interaction with both isoforms. In contrast, the NK3R interacted transiently with only beta-arrestin 2 at the plasma membrane. Despite these differences, both NK1R and NK3R similarly desensitized, internalized, and activated MAP kinases. Because interactions with beta-arrestins can explain differences in the rate of receptor resensitization, we compared resensitization of agonist-induced Ca2+ mobilization. The NK1R resensitized greater than twofold more slowly than the NK3R. Replacement of intracellular loop 3 and the COOH tail of the NK1R with comparable domains of the NK3R diminished colocalization of the NK1R with beta-arrestin 1 and accelerated resensitization to that of the NK3R. Thus loop 3 and the COOH tail specify colocalization of the NK1R with beta-arrestin 1 and determine the rate of resensitization.
authors.affiliation: Department of Surgery, University of California, San Francisco, 521 Parnassus Ave., San Francisco, CA 94143-0660, USA.
authors.forename: Fabien
authors.initials: F
authors.lastname: Schmidlin
authors.forename: Dirk
authors.initials: D
authors.lastname: Roosterman
authors.forename: Nigel W
authors.initials: NW
authors.lastname: Bunnett
mesh_terms: D000818:Animals; D019390:Arrestins / Q000378:metabolism*; D001692:Biological Transport / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D020013:Calcium Signaling; D002460:Cell Line; D004789:Enzyme Activation / Q000502:physiology; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D015287:Neurokinin B / Q000031:analogs & derivatives* / Q000494:pharmacology; D017434:Protein Structure, Tertiary / Q000502:physiology; D051381:Rats; D018040:Receptors, Neurokinin-1 / Q000819:agonists / Q000737:chemistry* / Q000378:metabolism*; D018042:Receptors, Neurokinin-3 / Q000819:agonists / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism*; D013373:Substance P / Q000031:analogs & derivatives* / Q000494:pharmacology; D014018:Tissue Distribution; D000071559:beta-Arrestin 1; D000071560:beta-Arrestin 2; D000071557:beta-Arrestins
chemical_list: C000605256:Arrb1 protein, rat; C000605257:Arrb2 protein, rat; D019390:Arrestins; D018040:Receptors, Neurokinin-1; D018042:Receptors, Neurokinin-3; D000071559:beta-Arrestin 1; D000071560:beta-Arrestin 2; D000071557:beta-Arrestins; C080394:neurokinin B, MePhe(7)-; C062618:substance P, Sar(9)-Met(O2)(11)-; D013373:Substance P; D015287:Neurokinin B; D020928:Mitogen-Activated Protein Kinases; D002118:Calcium